NCT01948193View on ClinicalTrials.gov

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth

PHASE3CompletedINTERVENTIONAL

Enrollment

177

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

June 30, 2015

Conditions

DiphtheriaTetanusWhooping CoughHepatitis BPoliomyelitisInvasive Hib Infections

Interventions

BIOLOGICAL

Hexaxim™: DTaP-IPV-Hep B-PRP~T combined vaccine

0.5 mL, Intramuscular

Trial Locations (2)

141008

Ludhiana

411043

Pune

All Listed Sponsors

lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01948193 - Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at Birth | Biotech Hunter | Biotech Hunter